Ruijin Hospital上海交通大学医学院附属瑞金医院
Official expert-directory headshot for Zhao Weili on the Ruijin Hospital website.
Department of Hematology

Zhao Weili

赵维莅

LeadershipVice President of Ruijin Hospital
ClinicalChief Physician, Professor, Doctoral Supervisor
Ruijin Hospital上海交通大学医学院附属瑞金医院· Shanghai

Areas of Expertise

Lymphoid malignanciesLymphoma and leukemiaTranslational hematologic oncology research including diffuse large B-cell lymphoma and CAR-T-related therapeutic strategy research
Request Consultation with Weili

Professional Biography

Dr. Zhao Weili is Chief Physician, Professor, Doctoral Supervisor at Ruijin Hospital, Shanghai. Weili specializes in Lymphoid malignancies, especially lymphoma and leukemia, with translational hematologic oncology research including diffuse large B-cell lymphoma and CAR-T-related therapeutic strategy research.

Notable Publications

Germ layer specification and organotropism in lymphoma invasion.

Science Bulletin (2026) — co-author

PubMed/DOI

Genetic and Transcriptomic Profiles Identify Potential Therapeutic Targets of Concurrent Follicular and Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma.

Hematological Oncology (2026) — co-author

PubMed/DOI

Leadership & Positions

  • Vice President, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
  • Executive Deputy Director, Shanghai Institute of Hematology
  • Executive Deputy Director, Department of Hematology, Ruijin Hospital

Pioneering Contributions

1

Built a national-level clinical and translational research program in lymphoid malignancies at Ruijin Hospital and the Shanghai Institute of Hematology, focused on lymphoma and leukemia.

2

Advanced molecular and transcriptomic characterization of aggressive B-cell lymphomas to identify therapeutic targets and biologic mechanisms of progression and invasion.

3

Contributed to CAR-T-related therapeutic strategy research in relapsed/refractory large B-cell lymphoma, including response-adapted combination approaches to improve CD19 CAR-T outcomes.

International Patient Services

Full support for your journey to China

Medipath provides comprehensive support for international patients. Services include full English-speaking medical consultations, dedicated medical translation staff, and specialized assistance with medical visa applications to ensure a seamless healthcare journey.

English Consultations

Full English-speaking medical appointments

Medical Translation

Dedicated translation for all documentation

Visa Assistance

Medical visa application support